...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith got a licensing upgrade.
Reply New Message
Back To Forum List View
Zenith got a licensing upgrade.

rocketman2
Nov 15, 2021 10:31AM
Re: Zenith got a licensing upgrade.
1
KOO-KOO2
Nov 15, 2021 02:51PM
Re: Zenith got a licensing upgrade.

rocketman2
Nov 15, 2021 04:33PM

Perhaps Zenith can pay out what is owed to Resverlogix in the amount of $872K US, in accordance with Sept 30, 2021 Financials.

Even better!  Resverlogix can take it out of our share of the Covid treatment sales.

 

Icon president Re: Zenith got a licensing upgrade.
6
RVXoldtimer
Nov 15, 2021 05:47PM
Re: Zenith got a licensing upgrade.
1
KOO-KOO2
Nov 16, 2021 08:16AM
Icon president Re: Zenith got a licensing upgrade.
2
RVXoldtimer
Nov 16, 2021 12:53PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply